{
    "clinical_study": {
        "@rank": "137739", 
        "arm_group": [
            {
                "arm_group_label": "Mannitol", 
                "arm_group_type": "Experimental", 
                "description": "Bolus mannitol 20% at skin incision"
            }, 
            {
                "arm_group_label": "Hypertonic saline", 
                "arm_group_type": "Experimental", 
                "description": "Hypertonic saline 3% at skin incision"
            }
        ], 
        "brief_summary": {
            "textblock": "Mannitol 20% has long been used to treat elevated intracranial hypertension in trauma and\n      intensive care settings. More recent data indicate that hypertonic saline may be as\n      effective or more effective than mannitol for this purpose, with possible fewer side\n      effects.\n\n      This study compares both agents in favoring cerebral relaxation during elective\n      supratentorial procedures for tumor resection.\n\n      Study hypothesis: 3% hypertonic saline will provide better cerebral relaxation with fewer\n      side effects than 20% mannitol."
        }, 
        "brief_title": "Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Osmotherapy", 
            "Intracranial Pressure"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients scheduled for elective supratentorial craniotomy for tumor resection\n\n          -  Presumed preoperative diagnosis of : astrocytoma (any grade), meningioma (any\n             sub-type) or cerebral metastasis (any primary neoplasm)\n\n        Exclusion Criteria:\n\n          -  Age < 18 years\n\n          -  Reintervention\n\n          -  Glasgow coma scale < 13\n\n          -  Emergency surgery or American Association of Anesthesiologists physical status class\n             4 or 5\n\n          -  Prone or lateral positioning\n\n          -  Hypo or hypernatremia (serum sodium below 135 or above 150 meq/L)\n\n          -  Osmotherapy (either mannitol or hypertonic saline) given in the last 24 hours\n\n          -  Congestive heart failure (LVEF < 40% or restrictive diastolic dysfunction on\n             echocardiography)\n\n          -  Chronic renal failure (creatinine clearance < 30 ml/min)\n\n          -  Pregnancy\n\n          -  Obesity (BMI > 40)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01745081", 
            "org_study_id": "Study on cerebral relaxation"
        }, 
        "intervention": [
            {
                "arm_group_label": "Mannitol", 
                "intervention_name": "20% mannitol bolus administration", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Hypertonic saline", 
                "intervention_name": "Hypertonic saline 3% bolus administration", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Mannitol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2012", 
        "location": {
            "contact": {
                "phone": "18193461110"
            }, 
            "facility": {
                "address": {
                    "city": "Sherbrooke", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "J1H5N4"
                }, 
                "name": "Centre hospitalier universitaire de Sherbrooke"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of the Efficacy Between 20% Mannitol and 3% Hypertonic Saline, Given as a Bolus at the Beginning of Elective Supratentorial Craniotomy for Tumor Resection, in Favoring Cerebral Relaxation Evaluated by a Sub-dural Intracranial Pressure Measurement.", 
        "overall_contact": {
            "email": "stephane.coutu@usherbrooke.ca", 
            "last_name": "St\u00e9phane Coutu, MD, FRCPC", 
            "phone": "8193461110", 
            "phone_ext": "14950"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Sub-dural measure of intracranial pressure to evaluate cerebral relaxation", 
            "measure": "Sub-dural intracranial pressure", 
            "safety_issue": "No", 
            "time_frame": "In average 30-60 minutes after intervention, just before dura mater opening"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01745081"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire de Sherbrooke", 
            "investigator_full_name": "St\u00e9phane Coutu", 
            "investigator_title": "Principal study investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Subjective evaluation by the surgeon of cerebral relaxation on a 4 point scale", 
                "measure": "Subjective evaluation of cerebral relaxation", 
                "safety_issue": "No", 
                "time_frame": "In average 30-60 minutes after intervention, just after dura mater opening"
            }, 
            {
                "description": "Serum lactate measurement to assess tissue perfusion during the procedure", 
                "measure": "Serum lactate", 
                "safety_issue": "Yes", 
                "time_frame": "In average 5-8 hours after intervention, upon arrival in the intensive care unit"
            }
        ], 
        "source": "Universit\u00e9 de Sherbrooke", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e9 de Sherbrooke", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}